Translational Regenerative Medicine Conference 2011

描述（由申请人提供）：再生医学基金会的转化再生医学（RM）论坛旨在成为再生医学翻译领导者的首要国际活动，代表学术和临床研究，医疗保健政策，监管，报销，风险投资和生物技术行业利益。该论坛旨在通过分享科学发现，最佳实践和商业模式来推动再生医学和医疗创新领域。会议反映了再生医学的全球范围，从美国和国际的角度，包括临床试验设计和获得监管批准等关键领域的主题演讲者和小组成员。翻译RM论坛和博览会现已进入第二个年头，是一项合作性的年度活动，旨在促进互动，加速疾病新疗法的发现和开发，并通过再生医学科学将这些疗法转化为患者的治疗方法。通过教育计划，翻译会议和公共政策倡议，再生医学基金会（RMF）倡导增加医学研究，促进科学家的培训和教育，并促进将疗法翻译给患者。2011年翻译RM论坛将在华盛顿，华盛顿特区的罗纳德里根大厦和国际贸易中心举行，2011年4月6日至8日，将由维克森林再生医学研究所共同赞助，该研究所是2010年翻译RM论坛的主办机构，安东尼·阿塔拉博士担任项目委员会的科学主席。2011年论坛的计划委员会和科学咨询理事会代表的完整名单详见研究计划。 公共卫生相关性：翻译再生医学论坛旨在成为再生医学翻译领导者的首要国际活动-代表学术和临床研究，医疗保健政策，监管，报销，风险投资和生物技术行业利益。该论坛是一个独特而重要的会议，因为它呼吁再生医学的所有利益相关者讨论再生医学的当前和未来前景。各行业提供的专业知识有助于了解需要解决的现有知识差距，以便成功地将科学从实验室转化为床边。

DESCRIPTION (provided by applicant): The Translational Regenerative Medicine (RM) Forum of the Regenerative Medicine Foundation is designed to be the premiere international event for leaders in regenerative medicine translation, representing academic and clinical research, healthcare policy, regulatory, reimbursement, venture investment and biotechnology industry interests. The Forum seeks to advance the field of regenerative medicine and healthcare innovation through the sharing of scientific discoveries, best practices and business models. Reflecting the global scope of regenerative medicine, the meeting features keynote speakers and panelists from a U.S. and international perspective -- including critical areas such as clinical trial design and obtaining regulatory approval. Now entering its second year, the Translational RM Forum and exposition is a collaborative, annual effort organized to foster interactions that will accelerate the discovery and development of new therapies for disease and translate those therapies into treatments for patients through the science of regenerative medicine. Through educational programs, translational conferences and public policy initiatives, the Regenerative Medicine Foundation (RMF) advocates for increased medical research, promotes the training and education of scientists, and facilitates the translation of therapies to patients. The Translational RM Forum 2011 will be held at the Ronald Regan Building and International Trade Centre, in Washington, D.C., April 6th - 8th, 2011 and will be co-sponsored by Wake Forest Institute for Regenerative Medicine, the institutional host of the Translational RM Forum of 2010, with Dr. Anthony Atala as the Scientific Chair of the program committee. The complete list of program committee and scientific advisory council representatives for the 2011 Forum are detailed in the research plan. PUBLIC HEALTH RELEVANCE: The Translational Regenerative Medicine Forum is designed to be the premiere international event for leaders in regenerative medicine translation -- representing academic and clinical research, healthcare policy, regulatory, reimbursement, venture investment and biotechnology industry interests. The Forum is a unique and important meeting as it calls all of the stakeholders in regenerative medicine to discuss the current and future landscape of regenerative medicine. The expertise presented by various industries, helps to develop an understanding of existing knowledge gaps that need to be addressed n order to successfully translate the science from bench to bedside.